MGRM
Monogram Orthopaedics Inc.
6.00$
-1.8%
vs. previous close
Closing price · As of: Jul 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -99.4% | +0.0% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | -99.6% | +0.0% | +10,638.2% | -100.0% | – | – | – | -0.8% | +1.4% | +1.9% | +0.8% | +0.9% | +1.4% | +96.3% | -49.2% | +38.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -98.9% | +0.0% | -10,838.2% | – | – | – | – | – | – | – | -140.7% | – | – | – | -150.8% | – | – | |
| – | 0.0% | +104.7% | +0.0% | +855.8% | +0.0% | -95.4% | +0.0% | +31,416.3% | +0.0% | -40.0% | +0.0% | +41.0% | 0.0% | +13.8% | +0.0% | -31.3% | +34.8% | -10.2% | +41.7% | +3.8% | +59.1% | -10.6% | +48.6% | -33.8% | +0.8% | -8.7% | -21.3% | +29.6% | 0.0% | – | |
| – | 0.0% | +60.7% | +0.0% | +74.9% | 0.0% | -71.1% | +0.0% | +809.7% | 0.0% | -35.7% | +0.0% | +226.6% | +0.0% | -44.9% | +0.0% | +78.3% | -3.1% | -6.1% | +119.0% | -31.3% | +31.8% | -2.2% | -58.3% | +145.0% | +3.0% | -2.0% | +2.3% | -7.7% | -25.2% | – | |
| – | +0.0% | +30.2% | +0.0% | +51.9% | +0.0% | +100.2% | +0.0% | +363.1% | +0.0% | -23.4% | +0.0% | +27.8% | +0.0% | +6.0% | +0.0% | +40.4% | -51.5% | -0.9% | +76.4% | +21.8% | +47.3% | -34.5% | +10.1% | -15.3% | +3.7% | +41.7% | -43.3% | +14.2% | -12.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -95.9% | +7,985.5% | -93.0% | -122.3% | – | – | – | -100.0% | +100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.